image
Keros Therapeutics, Inc. KROS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 14.04
-0.707 %
$ 570 M
Market Cap
-82.59
P/E
Price Target Average
626.50%
Revenue Forecast Estimate
147.65%
EBIT Estimate
40.34%
Net Income Estimate
11.65%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Keros Therapeutics, Inc.
image
Wall Street analysts predict an average 1-year price target for KROS of $102 , with forecasts ranging from a low of $96 to a high of $107 .
KROS Lowest Price Target Wall Street Target
96 USD 583.76%
KROS Average Price Target Wall Street Target
102 USD 626.50%
KROS Highest Price Target Wall Street Target
107 USD 662.11%
Price
Max Price Target
Min Price Target
Average Price Target
11011010010090908080707060605050404030302020101000Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart KROS

image
$200.0m$200.0m$180.0m$180.0m$160.0m$160.0m$140.0m$140.0m$120.0m$120.0m$100.0m$100.0m$80.0m$80.0m$60.0m$60.0m$40.0m$40.0m$20.0m$20.0m$0.0$0.0202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart KROS

image
$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)($140.0m)($140.0m)($160.0m)($160.0m)($180.0m)($180.0m)($200.0m)($200.0m)202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart KROS

image
$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)202120212022202220232023202420242025202520262026202720272028202820292029